The first axis will be focused on the mechanisms of mt-DNA expression and maintenance. We shall address the processes of mt-DNA replication, heteroplasmy and repair, RNA expression and maturation, organellar translation.
The second axis will address various mitochondria-nucleus cross-talk pathways involving macromolecules (proteins, RNA & DNA). mRNA targeting to mt-surface and mitochondrial import of small non-coding RNAs will be investigated. Proteins involved in mitochondria-nucleus cross-talk will be studied on the example of aaRSs, repair factors and PPR proteins. Dual-targeted proteins will also be studied. Mitochondrial functions reprogramming through natural events (by PPR, aaRSs) or induced by artificial agents (mt-targeted proteins, RNA, DNA) will also be addressed(all teams).
Finally, the third axis will be to address mitochondria-related pathologies. Without pretending to embrace the totality of adjacent problems, we will focus on mt-tRNA and aaRS - related dysfunctions of mt-translation and PPR and VDAC-related ones. Finally, the development of innovative approaches to deliver nucleic acids with potential therapeutic capacities into mitochondria will be addressed.
The MitoCross research cluster wishes to welcome one junior chair in Strasbourg. The chair will be...